14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 CNTA stock ended at $9.25. This is 2.32% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 2.81% from a day low at $9.24 to a day high of $9.50.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Jun 17, 2021 $24.63 $25.66 $24.00 $25.66 261 891
Jun 16, 2021 $24.23 $24.58 $23.50 $24.33 186 066
Jun 15, 2021 $24.80 $25.89 $23.45 $24.03 431 609
Jun 14, 2021 $22.03 $26.09 $22.00 $25.00 320 413
Jun 11, 2021 $21.00 $22.27 $20.40 $21.71 305 369
Jun 10, 2021 $21.89 $22.96 $21.31 $21.86 130 309
Jun 09, 2021 $22.71 $23.25 $21.50 $21.83 355 322
Jun 08, 2021 $23.06 $23.49 $22.34 $22.70 48 669
Jun 07, 2021 $24.68 $25.00 $22.19 $23.15 214 895
Jun 04, 2021 $22.02 $24.00 $22.02 $22.83 137 283
Jun 03, 2021 $24.14 $24.75 $20.68 $22.06 313 642
Jun 02, 2021 $23.26 $25.82 $22.00 $25.11 501 538
Jun 01, 2021 $20.75 $24.30 $20.48 $23.58 826 130
May 28, 2021 $20.25 $24.83 $20.00 $21.75 3 830 375
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT